BSPM - I'm predicting EPS of .20 vs. .03 due to increased popularity and affordability of their Hepatitis B drug, the only non-prescription drug in China approved for this condition .........
"which co,s reporting eps this coming week will announce the biggest upside surprises??? and why???"